Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Motrin and narcotic

Phase 3Small molecule

CCape Fear Valley Health System

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q3 2027

Post-ApprovalRecruiting

Pain

NCT06495632

Clinical

Trials by Indication[1]

Pain1 trial

Scheduled or As Needed Pain Regimen?

Recruiting·—·Phase 4·NCT06495632·90 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Motrin and narcotic. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Motrin and narcotic compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Motrin and narcotic. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Cape Fear Valley Health System company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: CCape Fear Valley Health System

Related News